CBBT Cerebain Biotech Corp
- 0.000
- 0.0000.00%
Cerebain Biotech Corp News
Cerebain Biotech Corp | REVOKED: Others
Cerebain Biotech Corp | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
Cerebain Biotech Corp | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
Cerebain Biotech Corp | NT 10-K: Others
Cerebain Biotech Corp | 8-K: Current report
Cerebain Biotech Corp | 10-Q: Q3 2019 Earnings Report
Cerebain Biotech Corp | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB
Cerebain Biotech Corp | DEF 14C: Definitive information statements
Cerebain Biotech Corp | 8-K: Current report
Cerebain Biotech Corp | PRE 14C: Preliminary information statement not related to a contested matter or merger/acquisition
Cerebain Biotech Corp | 10-Q: Q2 2019 Earnings Report
Cerebain Biotech Corp | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB
Cerebain Biotech Corp | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions
Cerebain Biotech Corp | 8-K: Current report
Cerebain Biotech Corp | 10-Q: Q1 2019 Earnings Report
Cerebain Biotech Corp | 10-K: FY2018 Annual Report
Cerebain Biotech Corp | 4: Statement of changes in beneficial ownership of securities
Cerebain Biotech Corp | 4: Statement of changes in beneficial ownership of securities
Cerebain Biotech Corp | 10-Q: Q3 2018 Earnings Report
Cerebain Biotech Corp | 8-K: Current report
Analysis
Price Target
No Data
No Data